Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-20 Sale |
2023-12-22 4:11 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
4,077 | $1.3807 | $5,629 | 97,996 (Direct) |
View |
| 2023-12-20 Sale |
2023-12-22 4:10 pm |
CytomX Therapeutics Inc. | CTMX | Ogden Christopher SVP, Finance and Accounting |
1,990 | $1.3806 | $2,747 | 48,657 (Direct) |
View |
| 2023-09-22 Sale |
2023-09-22 7:16 pm |
CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer |
4,119 | $1.3003 | $5,356 | 147,951 (Direct) |
View |
| 2023-09-22 Sale |
2023-09-22 7:15 pm |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
4,119 | $1.3003 | $5,356 | 84,059 (Indirect Direct) |
View |
| 2023-09-22 Sale |
2023-09-22 7:13 pm |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
14,601 | $1.3004 | $18,987 | 523,913 (Indirect Direct) |
View |
| 2023-09-22 Sale |
2023-09-22 7:12 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
5,486 | $1.3006 | $7,135 | 80,609 (Direct) |
View |
| 2023-03-29 Purchase |
2023-03-31 7:56 pm |
CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director |
5,000 | $1.55 | $7,750 | 5,142 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | Ogden Christopher SVP, Finance and Accounting |
516 | $1.9793 | $1,021 | 37,772 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
7,121 | $1.8805 | $13,391 | 481,979 (Indirect Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | Campoy Carlos Chief Financial Officer |
1,748 | $1.9791 | $3,459 | 38,224 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
2,037 | $1.979 | $4,031 | 71,095 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Financial Officer |
1,477 | $1.9792 | $2,923 | 76,928 (Indirect Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
4,257 | $1.979 | $8,425 | 58,433 (Direct) |
View |
| 2022-07-20 Sale |
2022-07-21 4:11 pm |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
7,463 | $1.422 | $10,612 | 62,690 (Direct) |
View |
| 2022-07-20 Sale |
2022-07-21 4:11 pm |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
4,206 | $1.4222 | $5,982 | 38,405 (Indirect Direct) |
View |
| 2022-07-20 Sale |
2022-07-21 4:10 pm |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
14,911 | $1.4222 | $21,206 | 384,100 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-17 Exercise |
2023-12-19 7:58 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Ogden Christopher SVP, Finance and Accounting |
6,875 | $0 | 57,522 (Direct) |
View |
| 2023-12-17 Exercise |
2023-12-19 7:57 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
37,500 | $0 | 598,913 (Direct) |
View |
| 2023-12-17 Exercise |
2023-12-19 7:56 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
11,250 | $0 | 109,629 (Direct) |
View |
| 2023-12-17 Exercise |
2023-12-19 7:55 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
11,250 | $0 | 113,323 (Direct) |
View |
| 2023-12-17 Exercise |
2023-12-19 7:54 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer |
11,250 | $0 | 170,451 (Direct) |
View |
| 2023-09-20 Option Award |
2023-09-22 7:16 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer |
11,250 | $0 | 147,951 (Direct) |
View |
| 2023-09-20 Option Award |
2023-09-22 7:15 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
11,250 | $0 | 84,059 (Direct) |
View |
| 2023-09-20 Option Award |
2023-09-22 7:13 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
40,000 | $0 | 523,913 (Direct) |
View |
| 2023-09-20 Option Award |
2023-09-22 7:12 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
15,000 | $0 | 80,609 (Direct) |
View |
| 2023-07-19 Option Award |
2023-07-20 5:18 pm |
N/A 2033-07-18 |
CytomX Therapeutics Inc. | CTMX | Chu Yu-Waye Chief Medical Officer |
375,000 | $0 | 375,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:54 pm |
N/A 2033-06-13 |
CytomX Therapeutics Inc. | CTMX | Meyers James R Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:52 pm |
N/A 2033-06-13 |
CytomX Therapeutics Inc. | CTMX | Mohindru Mani Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:51 pm |
N/A 2033-06-13 |
CytomX Therapeutics Inc. | CTMX | Young Matthew P. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:50 pm |
N/A 2033-06-13 |
CytomX Therapeutics Inc. | CTMX | Ashworth Alan Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:49 pm |
N/A 2033-06-13 |
CytomX Therapeutics Inc. | CTMX | Gilbert Halley E Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:49 pm |
N/A 2033-06-13 |
CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-23 4:52 pm |
N/A 2025-02-08 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
16,535 | $0 | 618,050 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-23 4:52 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
16,535 | $1.5749 | 618,050 (Direct) |
View |
| 2023-03-22 Option Award |
2023-03-29 7:54 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer |
60,000 | $0 | 140,820 (Direct) |
View |
Ownership |
2023-03-29 7:50 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer |
0 | $0 | 881,310 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 4:50 pm |
N/A 2033-02-01 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
720,000 | $0 | 1,104,100 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 4:49 pm |
N/A 2033-02-01 |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
215,000 | $0 | 253,405 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 4:48 pm |
N/A 2033-02-01 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
175,000 | $0 | 223,132 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 4:47 pm |
N/A 2033-02-01 |
CytomX Therapeutics Inc. | CTMX | Ogden Christopher SVP, Finance and Accounting |
175,000 | $0 | 188,288 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:01 pm |
N/A 2032-08-09 |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO |
525,000 | $0 | 525,000 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:00 pm |
N/A 2032-08-09 |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
157,500 | $0 | 157,500 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 4:59 pm |
N/A 2032-08-09 |
CytomX Therapeutics Inc. | CTMX | Ogden Christopher SVP, Finance and Accounting |
96,250 | $0 | 96,250 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 4:58 pm |
N/A 2032-08-09 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
157,500 | $0 | 157,500 (Direct) |
View |
| 2022-07-19 Option Award |
2022-07-21 4:11 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
20,000 | $0 | 62,690 (Direct) |
View |
| 2022-07-19 Option Award |
2022-07-21 4:11 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer |
11,250 | $0 | 38,405 (Direct) |
View |
| 2022-07-19 Option Award |
2022-07-21 4:10 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. President and CEO |
40,000 | $0 | 384,100 (Direct) |
View |